formestane has been researched along with Menopause in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (39.13) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delozier, T; Khayat, D; Spano, JP | 1 |
| Brodie, A; Coombes, RC; Dowsett, M; Gazet, JC; Goss, P | 1 |
| Adlercreutz, H; Fotsis, T; Johannessen, DC; Lønning, PE | 1 |
| Bajetta, E; Bichisao, E; Buzzoni, R; Celio, L; Noberasco, C; Zilembo, N | 1 |
| Ekse, D; Lønning, PE | 1 |
| Coombes, RC; Dowsett, M; Stein, RC | 1 |
| Coombes, RC; Dowsett, M; Hughes, SW | 1 |
| Coombes, RC | 1 |
| James, VH; Purohit, A; Reed, MJ | 1 |
| Coombes, RC; Dowsett, M; King, N; Mehta, A; Powles, TJ; Smith, IE; Stein, RC | 1 |
| Dowsett, M; Lønning, PE; Powles, TJ | 1 |
| Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC | 1 |
| Becher, R; Callies, R; Friederich, P; Höffken, K; Jonat, W; Kölbel, M; Kunz, T; Possinger, K; Wagner, H; Willmanns, W | 1 |
| Coombes, RC; Davenport, J; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC | 1 |
| Murray, P; Perry, L; Pickles, T; Plowman, P | 1 |
| Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA | 1 |
| Coombes, RC; Cunningham, DC; Dehennin, L; Dowsett, M; Evans, S; Hedley, A; Stein, RC | 1 |
| Brodie, AM; Coombes, RC; Dowsett, M; Gazet, JC; Goss, PE; Hutchison, G; Powles, TJ | 1 |
| Brodie, AM; Coombes, RC; Cunningham, D; Dowsett, M; Ford, HT; Gazet, JC; Hutchison, G; Powles, TJ | 1 |
| Brodie, AM; Coombes, RC; Dowsett, M; Goss, P; Wing, LY | 2 |
| Coombes, RC; Easton, D; Goss, PE; Singh, D; Wilkinson, JR; Williams, JC | 1 |
| Brodie, AM | 1 |
5 review(s) available for formestane and Menopause
| Article | Year |
|---|---|
[Aromatase inhibitors in adjuvant setting in breast cancer].
Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Menopause; Nitriles; Triazoles | 2004 |
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogens; Female; Goserelin; Humans; Menopause | 1992 |
Inhibition of oestrogen synthesis in postmenopausal women with breast cancer.
Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Arylsulfatases; Breast Neoplasms; Danazol; Estrogens; Female; Humans; Kinetics; Menopause; Steryl-Sulfatase | 1992 |
Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Fadrozole; Female; Humans; Imidazoles; Menopause; Nitriles | 1990 |
Aromatase inhibition and its pharmacologic implications.
Topics: Androstatrienes; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Kinetics; Macaca mulatta; Male; Mammary Neoplasms, Experimental; Menopause; Oligospermia; Oxidoreductases; Rats; Uterine Neoplasms | 1985 |
5 trial(s) available for formestane and Menopause
| Article | Year |
|---|---|
4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Estradiol; Female; Humans; Injections, Intramuscular; Menopause; Middle Aged; Time Factors | 1992 |
An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Female; Humans; Menopause; Middle Aged | 1992 |
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
Topics: Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Ovariectomy | 1990 |
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Estradiol; Female; Germany, West; Humans; Life Tables; Menopause; Middle Aged; Multicenter Studies as Topic; Receptors, Estrogen; Remission Induction; Tamoxifen | 1990 |
Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.
Topics: Administration, Oral; Androstenedione; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Half-Life; Humans; Injections, Intramuscular; Menopause; Sex Hormone-Binding Globulin | 1989 |
13 other study(ies) available for formestane and Menopause
| Article | Year |
|---|---|
4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer.
Topics: Adult; Aged; Androstenedione; Animals; Bone Neoplasms; Breast Neoplasms; Castration; Estradiol; Female; Humans; Injections, Intramuscular; Menopause; Mice; Middle Aged | 1984 |
Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.
Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Male; Menopause; Middle Aged | 1993 |
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy.
Topics: Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Remission Induction; Tamoxifen; Treatment Outcome | 1993 |
A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrone; Female; Humans; Hydrolysis; Menopause; Radioimmunoassay; Sensitivity and Specificity | 1995 |
4-Hydroxyandrostenedione treatment for postmenopausal patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Menopause; Middle Aged | 1992 |
Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Estradiol; Female; Humans; Menopause; Middle Aged | 1990 |
4-hydroxyandrostenedione--further clinical and extended endocrine observations.
Topics: Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Endocrine Glands; Female; Humans; Menopause; Middle Aged | 1990 |
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen | 1989 |
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
Topics: Adult; Aged; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Drug Evaluation; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Sex Hormone-Binding Globulin | 1986 |
Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer.
Topics: Administration, Oral; Adult; Aged; Androstenedione; Breast Neoplasms; Estradiol; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Ovariectomy | 1987 |
Aromatase inhibitors and the treatment of breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Kinetics; Luteinizing Hormone; Macaca mulatta; Mammary Neoplasms, Experimental; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Rats; Tamoxifen | 1986 |
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response.
Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Dihydrotestosterone; Female; Humans; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Ovariectomy; Rats; Tamoxifen | 1986 |
Aromatase inhibitors and their potential clinical significance.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Menopause; Ovary; Rats | 1986 |